Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers-Reference-Cited by-同舟云学术

Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers

Published:2021-05 Issue: Volume:Volume 15 Page:2211-2227
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Sarwar Sadia^ORCID,Alamro Abir A^ORCID,Alghamdi Amani A^ORCID,Naeem Komal^ORCID,Ullah Salamat^ORCID,Arif Muazzam,Yu Jun Qing,Huq Fazlul

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference37 articles.

1. Surveillance, Epidemiology & End Results Program at the National Institute of Health. SEER stat fact sheets: ovary cancer. Available from: http://seer.cancer.gov/statfacts/html/ovary.html. Accessed April 28, 2021.

2. Surveillance, Epidemiology and End Results Program at the National Institute of Health. SEER stat fact sheets: ovary cancer. Available from: http://seer.cancer.gov/statfacts/html/ovary.html. Accessed April 28, 2021.

3. Hormone therapy in epithelial ovarian cancer.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis;Heliyon;2024-09

2. Molecular mechanisms of cisplatin resistance in ovarian cancer;Genes & Diseases;2023-08

3. Wedelolactone: A molecule of interests;Fitoterapia;2023-01

4. Investigations of cellular copper metabolism in ovarian cancer cells using a ratiometric fluorescent copper dye;JBIC Journal of Biological Inorganic Chemistry;2022-12-05

5. Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway;Pharmacological Research;2022-09